Article Text
Abstract
Primary sclerosing cholangitis (PSC) is a rare chronic autoimmune disease with no effective therapy and a large unmet need for new treatments. Patients require significant healthcare resources over their lifetime with high rates of hospital admission, malignancy, liver transplantation and death. As a rare disease, expertise in management can be limited to large referral liver transplant programmes, and even then there is frequently variation in practice. In this case-based review, we aim to discuss common clinical dilemmas encountered by clinicians managing patients with PSC and address related competencies in the 2010 Gastroenterology Curriculum.
- autoimmune liver disease
- cholestatic liver diseases
- inflammatory bowel diseases
- orthotopic liver transplantation
- primarysclerosing colangitis
Statistics from Altmetric.com
Footnotes
Contributors GMH developed the idea for the article. KA wrote the article with supervision from GMH.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.